日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development and validation of prediction algorithm to identify tuberculosis in two large California health systems

开发和验证用于识别加州两大医疗系统中结核病的预测算法

Fischer, Heidi; Qian, Lei; Li, Zhuoxin; Bruxvoort, Katia; Skarbinski, Jacek; Ni, Yuching; Ku, Jennifer H; Lewin, Bruno; Garba, Saadiq; Mahale, Parag; Shaw, Sally F; Spence, Brigitte; Tartof, Sara Y

FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer

FDA批准摘要:Datopotamab Deruxtecan-dlnk用于治疗不可切除或转移性、HR阳性、HER2阴性乳腺癌患者

Royce, Melanie; Shah, Mirat; Zhang, Lijun; Cheng, Joyce; Bonner, Mary Kate; Pegues, Melissa; Miller, Claudia P; Leu, Lily; Price, Lauren S L; Qiu, Junshan; Yu, Jingyu; Truong, Tien M; Dorff, Sarah E; Yang, Yuching; Zhang, Nailing; Gutierrez-Lugo, Maria; Ricks, Tiffany K; Pierce, William F; Luo, Zhongjun; Kappel, Dana; Goldberg, Kirsten B; Shord, Stacy S; Tang, Shenghui; Bhatnagar, Vishal; Pazdur, Richard; Kluetz, Paul G; Amiri-Kordestani, Laleh

FDA Approval Summary: Vorasidenib for IDH-Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery

FDA批准摘要:Vorasidenib用于IDH突变型2级星形细胞瘤或少突胶质细胞瘤术后治疗

Barbato, Michael I; Barone, Amy K; Aungst, Stephanie L; Miller, Claudia P; Ananthula, Suryatheja; Bi, Youwei; Yang, Yuching; Li, Xiaoxue; Xiong, Ye; Fan, Jianghong; Dorff, Sarah E; Zhao, Hong; Zhou, Hua; Pradhan, Shan; Scepura, Barbara; Sinha, Arup K; Stephenson, Maritsa; Bhatnagar, Vishal; Saber, Haleh; Rahman, Nam Atiqur; Tang, Shenghui; Pazdur, Richard; Kluetz, Paul G; Larkins, Erin; Drezner, Nicole

FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma

FDA批准摘要:托沃拉非尼用于治疗复发或难治性BRAF突变型儿童低级别胶质瘤

Singh, Sonia; Bradford, Diana; Chatterjee, Somak; Li, Xiaoxue; Aungst, Stephanie L; Skinner, Amy M; Miller, Claudia P; Kim-McOlash, Sarah; Fourie Zirkelbach, Jeanne; Xiong, Ye; Bi, Youwei; Wang, Ying-Hong; Yang, Yuching; Sun, Jielin; Kraft, Jeffrey; Charlab, Rosane; Shord, Stacy S; Tang, Shenghui; Scepura, Barbara; Bulatao, Ilynn; Udoka, Opeyemi; Saber, Haleh; Rahman, Nam Atiqur; Pazdur, Richard; Singh, Harpreet; Donoghue, Martha; Drezner, Nicole

Injectable sustainable andrographolide-releasing hydrogel for long-lasting alleviation of osteoarthritis and regulation of chondrocyte autophagy via PRKCA/EGFR.

可注射的可持续穿心莲内酯释放水凝胶,通过 PRKCA/EGFR 长期缓解骨关节炎并调节软骨细胞自噬

Chen Yang, He Peipei, Tao Siyi, Zhong Jintao, Jiang Kai, Hsu Yuching, Xia Guang, Mao Xinzhan, Sang Hongxun, Lu Ke

MMP12-dependent myofibroblast formation contributes to nucleus pulposus fibrosis.

MMP12依赖性肌成纤维细胞形成导致髓核纤维化

Sun Yi, Tam Wai-Kit, Zhu Manyu, Lu Qiuji, Yu Mengqi, Hsu Yuching, Chen Peng, Zhang Peng, Lyu Minmin, Huang Yongcan, Zheng Zhaomin, Zhang Xintao, Leung Victor Y

Considerations for Regulatory Reusability of Dynamic Tools in the New Drug Development

新药研发中动态工具监管可重用的考量

Liu, Jiang; Yang, Yuching; Gobburu, Joga; Musante, Cynthia J; Klein, Martin; Zhao, Liang; Madabushi, Rajanikanth; Zhu, Hao

Invisible appliance promotes bone reconstruction via modulating the periodontal immune microenvironment.

隐形矫治器通过调节牙周免疫微环境促进骨骼重建

Wong HiuChing, Huang Yuching, Yang Pu

In vitro culture and confocal microscopy study of Maritrema gratiosum Nicoll, 1907 (Digenea): From metacercaria to ovigerous adult.

体外培养和共聚焦显微镜研究 Maritrema gratiosum Nicoll, 1907 (Digenea): 从囊蚴到抱卵成虫

Chuang YuChing, Shinn Andrew P, Bron James E

FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

FDA批准摘要:Pirtobrutinib用于治疗复发或难治性套细胞淋巴瘤

Telaraja, Deepti; Kasamon, Yvette L; Collazo, Justin S; Leong, Ruby; Wang, Kun; Li, Ping; Dahmane, Elyes; Yang, Yuching; Earp, Justin; Grimstein, Manuela; Rodriguez, Lisa R; Theoret, Marc R; Gormley, Nicole J